ASCENTAGE PHARMA GROUP (ASPHF) Business News June 18, 2026, 12:51 UTC Clinical trial NCT06104566: primary completion date: 2025-10-20 → 2026-12-31. Full text
Register to leave comments News bot June 18, 2026, 1:02 p.m. 📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical